81 related articles for article (PubMed ID: 38755637)
1. Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells.
Pang J; Shen N; Yan F; Zhao N; Dou L; Wu LC; Seiler CL; Yu L; Yang K; Bachanova V; Weaver E; Tretyakova NY; Liu S
Oncotarget; 2017 May; 8(21):34453-34467. PubMed ID: 28415607
[TBL] [Abstract][Full Text] [Related]
2. The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma.
Cheng A; Xu Q; Li B; Zhang L; Wang H; Liu C; Han Z; Feng Z
Cell Death Dis; 2024 May; 15(5):376. PubMed ID: 38811531
[TBL] [Abstract][Full Text] [Related]
3. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma.
Liu Y; Sun Y; Yang J; Wu D; Yu S; Liu J; Hu T; Luo J; Zhou H
Mol Cancer; 2024 May; 23(1):104. PubMed ID: 38755637
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation-based depiction of the immune microenvironment and immune-associated long non-coding RNAs in oral cavity squamous cell carcinomas.
Calanca N; Francisco ALN; Bizinelli D; Kuasne H; Barros Filho MC; Flores BCT; Pinto CAL; Rainho CA; Soares MBP; Marchi FA; Kowalski LP; Rogatto SR
Biomed Pharmacother; 2023 Nov; 167():115559. PubMed ID: 37742611
[TBL] [Abstract][Full Text] [Related]
5. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Glaviano A; Foo ASC; Lam HY; Yap KCH; Jacot W; Jones RH; Eng H; Nair MG; Makvandi P; Geoerger B; Kulke MH; Baird RD; Prabhu JS; Carbone D; Pecoraro C; Teh DBL; Sethi G; Cavalieri V; Lin KH; Javidi-Sharifi NR; Toska E; Davids MS; Brown JR; Diana P; Stebbing J; Fruman DA; Kumar AP
Mol Cancer; 2023 Aug; 22(1):138. PubMed ID: 37596643
[TBL] [Abstract][Full Text] [Related]
6. Discovery and identification of a novel PI3K inhibitor with enhanced CDK2 inhibition for the treatment of triple negative breast cancer.
Yang C; Wang M; Gong Y; Deng M; Ling Y; Li Q; Wang J; Zhou Y
Bioorg Chem; 2023 Nov; 140():106779. PubMed ID: 37579621
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms insulating proliferation from genotoxic stress in B lymphocytes.
Wright NE; Mandal M; Clark MR
Trends Immunol; 2023 Sep; 44(9):668-677. PubMed ID: 37573227
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic DNA methyltransferase 1 activates the PI3K/AKT/mTOR signalling by blocking the binding of HSPB8 and BAG3 in melanoma.
Yang Y; Ma S; Ye Z; Zheng Y; Zheng Z; Liu X; Zhou X
Epigenetics; 2023 Dec; 18(1):2239607. PubMed ID: 37523636
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of DNA key protein-FEN1 inhibits OSCC growth by affecting immunosuppressive phenotypes via IFN-γ/JAK/STAT-1.
Wang S; Wang X; Sun J; Yang J; Wu D; Wu F; Zhou H
Int J Oral Sci; 2023 Apr; 15(1):17. PubMed ID: 37185662
[TBL] [Abstract][Full Text] [Related]
10. Single-cell transcriptome profiling of the stepwise progression of head and neck cancer.
Choi JH; Lee BS; Jang JY; Lee YS; Kim HJ; Roh J; Shin YS; Woo HG; Kim CH
Nat Commun; 2023 Feb; 14(1):1055. PubMed ID: 36828832
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis combined with clinical sample screening reveals that leptin may be a biomarker of preeclampsia.
Wang Y; Bai X; Guo X; Gao X; Chen Y; Li H; Fan W; Han C
Front Physiol; 2022; 13():1031950. PubMed ID: 36685185
[No Abstract] [Full Text] [Related]
12. Cell division drives DNA methylation loss in late-replicating domains in primary human cells.
Endicott JL; Nolte PA; Shen H; Laird PW
Nat Commun; 2022 Nov; 13(1):6659. PubMed ID: 36347867
[TBL] [Abstract][Full Text] [Related]
13. Novel epigenetic therapeutic strategies and targets in cancer.
Babar Q; Saeed A; Tabish TA; Pricl S; Townley H; Thorat N
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166552. PubMed ID: 36126898
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma.
Yang SC; Wang WY; Zhou JJ; Wu L; Zhang MJ; Yang QC; Deng WW; Sun ZJ
Int Immunopharmacol; 2022 Oct; 111():109113. PubMed ID: 35944462
[TBL] [Abstract][Full Text] [Related]
15. DNMT1-mediated epigenetic silencing of TRAF6 promotes prostate cancer tumorigenesis and metastasis by enhancing EZH2 stability.
Li Z; Li B; Yu H; Wang P; Wang W; Hou P; Li M; Chu S; Zheng J; Mao L; Bai J
Oncogene; 2022 Aug; 41(33):3991-4002. PubMed ID: 35804015
[TBL] [Abstract][Full Text] [Related]
16. Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer.
Redman JM; Friedman J; Robbins Y; Sievers C; Yang X; Lassoued W; Sinkoe A; Papanicolau-Sengos A; Lee CC; Marte JL; Turkbey E; Mydlarz W; Joshi A; London NR; Pierce M; Taylor R; Hong S; Nguyen A; Soon-Shiong P; Schlom J; Gulley JL; Allen CT
J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35727629
[TBL] [Abstract][Full Text] [Related]
17. Detecting Early-Stage Oral Cancer from Clinically Diagnosed Oral Potentially Malignant Disorders by DNA Methylation Profile.
Mori K; Hamada T; Beppu M; Tsuchihashi H; Goto Y; Kume K; Hijioka H; Nishi K; Mishima Y; Sugiura T
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681626
[TBL] [Abstract][Full Text] [Related]
18. ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy.
Fan H; He Y; Xiang J; Zhou J; Wan X; You J; Du K; Li Y; Cui L; Wang Y; Zhang C; Bu Y; Lei Y
Redox Biol; 2022 Jul; 53():102339. PubMed ID: 35636017
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
